Physician profile
Daniel J Mchugh
NPI 1790766319
$6,253.17
in general payments reported to CMS, 2019-2025
44 companies · $1,235 in 2025
The $1,235 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,061 · 2020: $453 · 2021: $1,142 · 2022: $700 · 2023: $580 · 2024: $1,081 · 2025: $1,235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,896.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $784.35 | 2019-2025 | Proclaim |
| Collegium Pharmaceutical, INC. | $627.27 | 2019-2025 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $580.59 | 2019-2025 | Relistor, Trulance |
| Lundbeck LLC | $439.29 | 2020-2025 | Vyepti |
| Pfizer INC. | $362.15 | 2019-2024 | |
| Boston Scientific Corporation | $329.18 | 2022-2025 | Wavewriter Alpha Prime 16 |
| Amgen INC. | $251.60 | 2019-2023 | Aimovig |
| Lilly USA, LLC | $215.98 | 2019-2023 | Reyvow, Emgality |
| Abbvie INC. | $204.83 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $190.93 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $175.42 | 2024-2025 | |
| Stryker Corporation | $170.32 | 2025 | Mild Device Kit |
| Scilex Pharmaceuticals INC. | $165.56 | 2019-2025 | Ztlido |
| Arbor Pharmaceuticals, INC. | $164.69 | 2019-2021 | |
| Relievant Medsystems, INC. | $123.68 | 2022 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Mchugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.